GGrantIndex
Sort

15,440 grants matching organoids

Novel Antimicrobial Approach to Treat Chemoradiation Resistant Cervical Cancer by Selectively Inhibiting Lactobacillus iners

$295,881
Laurel A. Lagenaur · Osel, Inc. · R43 · FY2025 · CA

Model Systems Core

$295,857
Arohan R Subramanya · University Of Pittsburgh At Pittsburgh · U54 · FY2023 · DK

Model Systems Core

$295,856
Arohan R Subramanya · University Of Pittsburgh At Pittsburgh · U54 · FY2024 · DK

Multi-organ metastatic breast cancer cell-based assay platform that models organotropic metastases using patient organoids in human tissue-derived ECMs to accelerate anti-metastatic drug development

$295,604
John David O'Neill · Xylyx Bio, Inc. · R44 · FY2024 · CA

Pathology Core

$295,583
Christopher Paul Crum · Dana-Farber Cancer Inst · P50 · FY2021 · CA

A novel strategy to overcome drug resistance in cancer

$295,488
Aimee L Edinger · University Of California-Irvine · R01 · FY2025 · CA

Core C: Imaging: from Super-Resolution to Whole Animal

$295,327
Mikala Egeblad · Cold Spring Harbor Laboratory · P01 · FY2022 · CA

Targeting Cholesterol Homeostasis to maintain vision in MS-like optic neuritis

$295,245
Oliver W Gramlich · University Of Alabama At Birmingham · R01 · FY2025 · EY

Biostatistics Core

$295,240
Steven J Skates · Dana-Farber Cancer Inst · P50 · FY2021 · CA

Research Project 2: Identify and validate efficacious therapies for metastatic breast cancer

$295,107
Alana L Welm · Utah State Higher Education System--University Of Utah · U54 · FY2025 · CA

Project 1: Race-related RNA splicing in non-small cell lung cancer: functional interrogation and therapeutic targeting

$295,093
Jennifer Ann Freedman · Duke University · P20 · FY2020 · CA

Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility

$295,087
Kathleen Siebenlist · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA

Molecular and neurodevelopmental consequences of ADNP mutation

$295,070
Kavitha Sarma · Wistar Institute · R21 · FY2021 · MH

SBIR Phase I: AI-driven PROTAC drug discovery - Pioneering non-hormonal therapeutic targets for uterine fibroids and endometriosis

$295,000
Morgan M Stanton · Opal Therapeutics Inc · · FY2024 · TIP

Core 1: Animal and Cell Model Core

$294,995
Guido Erwin Michael Eibl · University Of California Los Angeles · P01 · FY2020 · CA

Viral Diversity and Pathogenicity in Mucosal Respiratory and Gastrointestinal Disease

$294,924
Mary Kolb Estes · Baylor College Of Medicine · U19 · FY2021 · AI

Mucosal determinants of Cryptosporidium infection

$294,923
Pablo C Okhuysen · Baylor College Of Medicine · U19 · FY2020 · AI

Predicting Tumor Heterogeneity Evolution After Therapy in Patient-derived Ex Vivo Glioblastoma Organoids

$294,336
Aleksander Skardal · Ohio State University · R21 · FY2019 · CA

Clinical Core

$294,048
Philip Magnus Grant · Stanford University · U19 · FY2022 · AI

Craniofacial cartilage differentiation from human neural crest stem cells in 3D cultures

$294,000
Mark Lindsay Grimes · University Of Montana · R03 · FY2024 · DE

A Mucus-producing Intestinal Epithelium Model for In Vitro Drug Absorption Testing

$293,991
Bill Thelin · Altis Biosystems, Inc. · R43 · FY2022 · DK

The Role of Cellular-Spatial Neighborhoods in Tonsil Organoid Immunology.

$293,948
Garry P Nolan · Stanford University · U19 · FY2021 · AI

Metabolic regulation of FOLFIRINOX acquired resistance in pancreatic cancer

$293,941
Pankaj Kumar Singh · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2022 · CA

Model Systems Core

$293,842
Arohan R Subramanya · University Of Pittsburgh At Pittsburgh · U54 · FY2025 · DK

Establishing Acomys as a genetic platform for regeneration research

$293,550
Kathleen Joyce Millen · Seattle Children'S Hospital · R21 · FY2024 · OD